Premium
A time kinetic study of the effect of aminobisphosphonate on murine haemopoiesis
Author(s) -
Nakamura Masanori,
Yagi Hideki,
Endo Yasuo,
Kosugi Hiroshi,
Ishi Tadashi,
Itoh Tsunetoshi
Publication year - 1999
Publication title -
british journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.907
H-Index - 186
eISSN - 1365-2141
pISSN - 0007-1048
DOI - 10.1046/j.1365-2141.1999.01774.x
Subject(s) - granulopoiesis , erythropoiesis , haematopoiesis , bone marrow , progenitor cell , in vivo , resorption , macrophage , bone resorption , spleen , biology , myelopoiesis , osteoclast , immunology , medicine , endocrinology , andrology , stem cell , microbiology and biotechnology , in vitro , biochemistry , anemia
We previously showed that aminobisphosphonates (aminoBPs), potent inhibitors of bone resorption, increased the number of osteoclasts and granulocytes, and enhanced the cell size of osteoclasts in vivo , indicating that aminoBPs have a profound effect on murine haemopoiesis. The possible effect of an aminoBP (4‐amino‐1‐hydroxybutylidene‐1,1‐bisphosphonate; AHBuBP) on murine haemopoiesis in vivo was examined in more detail. Macroscopically, AHBuBP induced the whitened bone marrow (BM) and splenomegaly. Flow cytometric analysis indicated that in BM, AHBuBP reduced the number of mature monocyte‐macrophage lineage cells and erythroid cells 1 and 2 d after treatment, respectively, whereas it enhanced granulopoiesis on day 4. In the spleen, both erythropoiesis and granulopoiesis were significantly increased. BM haemopoietic progenitors of granulocyte lineage and of monocyte‐macrophage lineage (CFU‐G, CFU‐M and CFU‐GM) were well maintained by the injection of AHBuBP, and even a small increment in these progenitors was observed 2–4 d after treatment. Immunohistochemical examination of BM demonstrated that residential macrophages of erythroblastic islands disappeared. Increased numbers of osteoclasts, as well as enlarged cell size, was confirmed up to 7 d after the treatment, implicating that the inhibition of bone resorption was not due to the reduced generation of osteoclasts by AHBuBP. These results suggest (1) that AHBuBP treatment in vivo rapidly deleted mature residential macrophages from BM, (2) that mature macrophages once deleted did not reappear even when CFU‐M and CFU‐GM increased in number and the number of Mac‐1 + /Gr‐1 − cells recovered to normal, (3) that BM erythropoiesis was significantly decreased due to the lack of erythroblastic islands, and (4) that compensatory erythropoiesis was evoked in the spleen to induce splenomegaly.